1. Gadebusch, H. H., Koupal, L. R., Celozzi, E., Shungu, D. L., Bland, J., Weissberger, B., Pelak, B. A., Fisch, E., Chung, S. K., Huber, J.: Norfloxacin (MK-0366, AM-715), a new orally absorbed synthetic compound for the treatment of bacterial infections. In: Periti, P., Gialdroni Grassi, G. (ed.): Current chemotherapy and immunotherapy, Volume 1. American Society for Microbiology, Washington, D.C., 1982, p. 351–353.
2. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrobial Agents and Chemotherapy 1980, 17: 103–108.
3. Stanier, R. Y., Adelberg, E. A., Ingraham, J. L.: The microbial world. Prentice-Hall, Englewood Cliffs, NJ, 1976, p. 441–444.